Dr Reddy's Laboratories to acquire German medical firm Nimbus Health

Feb 03, 2022

Hyderabad (Telangana) [India], February 3 : Dr Reddy's Laboratories said on Thursday it has entered into a definitive agreement to acquire German medical cannabis...

Dr Reddy's Laboratories posts Rs 707 crore profit in Q3

Jan 28, 2022

Hyderabad (Telangana) [India], January 28 : Dr. Reddy's Laboratories on Friday reported Rs 707 crore net profit for the third quarter of the current...

Dr Reddy's laboratories gets DCGI's nod to launch Molnupiravir capsules in India

Dec 28, 2021

Hyderabad (Telangana) [India], December 28 : Drugs Controller General of India (DCGI) on Tuesday approved Dr Reddy's laboratories for the emergency-use authorisation) to manufacture...

Dr Reddy's Laboratories isolates all its data centre services following cyber attack

Oct 23, 2020

Hyderabad (Telangana) [India], October 23 : The pharmaceutical company Dr Reddy's Laboratories Ltd has isolated all its data centres following a cyber attack on...

Dr Reddy's Laboratories announces commercial launch of anti-COVID-19 drug 2-DG

Jun 28, 2021

Hyderabad (Telangana) [India], June 28 : Dr. Reddy's Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-COVID-19 drug.

Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment

Sep 09, 2020

Hyderabad (Telangana) [India], September 9 : Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.